Bruker Corporation to Present at Upcoming Investor Conferences
Bruker (Nasdaq: BRKR) has announced its participation in two upcoming investor conferences. Gerald Herman, Executive Vice President & CFO, will represent the company at both events:
1. The 2024 Wells Fargo Healthcare Conference in Boston, MA on Wednesday, September 4, 2024, at 10:15 a.m. Eastern Time.
2. The Morgan Stanley 22nd Annual Global Healthcare Conference in New York City on Friday, September 6, 2024, at 10:00 a.m. Eastern Time.
Live audiovisual webcasts of the presentations will be available on the company's Investor Relations website. Replays will be accessible for 90 days after the events in the 'Events & Presentations' section.
Bruker (Nasdaq: BRKR) ha annunciato la sua partecipazione a due prossime conferenze per investitori. Gerald Herman, Vicepresidente Esecutivo e CFO, rappresenterà l'azienda in entrambi gli eventi:
1. La Wells Fargo Healthcare Conference 2024 a Boston, MA, mercoledì 4 settembre 2024, alle 10:15 ora orientale.
2. La 22a Conferenza Globale sulla Sanità di Morgan Stanley a New York City, venerdì 6 settembre 2024, alle 10:00 ora orientale.
Le presentazioni saranno disponibili in diretta tramite webcast audiovisivi sul sito web delle Relazioni con gli Investitori dell'azienda. Le registrazioni saranno accessibili per 90 giorni dopo gli eventi nella sezione 'Eventi e Presentazioni'.
Bruker (Nasdaq: BRKR) ha anunciado su participación en dos próximas conferencias para inversionistas. Gerald Herman, Vicepresidente Ejecutivo y CFO, representará a la empresa en ambos eventos:
1. La Conferencia de Atención Médica Wells Fargo 2024 en Boston, MA, el miércoles 4 de septiembre de 2024, a las 10:15 a.m. hora del Este.
2. La 22ª Conferencia Anual Global de Atención Médica de Morgan Stanley en la ciudad de Nueva York, el viernes 6 de septiembre de 2024, a las 10:00 a.m. hora del Este.
Las presentaciones se transmitirán en vivo a través de webcasts audiovisuales en el sitio web de Relaciones con Inversionistas de la empresa. Las repeticiones estarán disponibles por 90 días después de los eventos en la sección 'Eventos y Presentaciones'.
Bruker (Nasdaq: BRKR)는 두 개의 예정된 투자자 회의에 참석할 예정이라고 발표했습니다. Gerald Herman, 최고 재무 책임자(CFO)가 두 행사에서 회사를 대표합니다:
1. 2024 웰스파고 헬스케어 콘퍼런스가 매사추세츠주 보스턴에서 2024년 9월 4일 수요일 동부 표준시로 오전 10시 15분에 열립니다.
2. 모건스탠리 제22회 연례 글로벌 헬스케어 콘퍼런스가 뉴욕시에서 2024년 9월 6일 금요일 동부 표준시로 오전 10시에 열립니다.
프레젠테이션의 생방송 오디오 비주얼 웹캐스트는 회사의 투자자 관계 웹사이트에서 제공됩니다. 이벤트 이후 90일 동안 '이벤트 및 프레젠테이션' 섹션에서 다시 보기 가능.
Bruker (Nasdaq: BRKR) a annoncé sa participation à deux prochaines conférences pour investisseurs. Gerald Herman, Vice-Président Exécutif et CFO, représentera l'entreprise lors de ces deux événements :
1. La Conférence de Santé Wells Fargo 2024 à Boston, MA, le mercredi 4 septembre 2024, à 10h15, heure de l'Est.
2. La 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley à New York, le vendredi 6 septembre 2024, à 10h00, heure de l'Est.
Des webcasts audiovisuels en direct des présentations seront disponibles sur le site des Relations Investisseurs de l'entreprise. Les rediffusions seront accessibles pendant 90 jours après les événements dans la section 'Événements & Présentations'.
Bruker (Nasdaq: BRKR) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. Gerald Herman, Executive Vice President & CFO, wird das Unternehmen bei beiden Veranstaltungen vertreten:
1. Die Wells Fargo Healthcare Conference 2024 in Boston, MA, am Mittwoch, den 4. September 2024, um 10:15 Uhr Eastern Time.
2. Die 22. Morgan Stanley Annual Global Healthcare Conference in New York City am Freitag, den 6. September 2024, um 10:00 Uhr Eastern Time.
Live-Audiovisuelle Webcasts der Präsentationen sind auf der Investor Relations-Website des Unternehmens verfügbar. Wiederholungen sind 90 Tage nach den Veranstaltungen im Bereich 'Ereignisse & Präsentationen' zugänglich.
- None.
- None.
2024 Wells Fargo Healthcare Conference in
Wednesday, September 4, 2024, at 10:15 a.m. Eastern Time
Morgan Stanley 22nd Annual Global Healthcare Conference in
Friday, September 6, 2024, at 10:00 a.m. Eastern Time
Live audiovisual webcasts of the presentations will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. Replays of the presentations will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the events and will be available for 90 days following the presentations.
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240823605948/en/
Joe Kostka
Associate Director, Investor Relations
Bruker Corporation
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com
Source: Bruker Corporation
FAQ
When is Bruker (BRKR) presenting at the 2024 Wells Fargo Healthcare Conference?
Who will represent Bruker (BRKR) at the upcoming investor conferences?
Where can I watch the live webcast of Bruker 's (BRKR) presentations?
How long will the replays of Bruker 's (BRKR) presentations be available?
